The researchers found that this treatment was beneficial in reducing pain while also improving quality of life. “Medical cannabis treatment with the Syqe Inhaler demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects in a cohort of patients with chronic pain, using just a fraction of the amount of MC [medical cannabis] compared with other modes of delivery by inhalation. These outcomes were accompanied by a lower rate of AEs [adverse events] and almost no AE reports during a long-term steady-state follow-up. Additional follow-ups in a larger population is warranted to corroborate our findings,” the authors concluded.
Ladies and gentlemen, we have a new contender for the most audacious cannabis caper of…
How much should an ounce of weed cost? As the U.S. cannabis market surges past…
Find the best high-potency hemp products of 2025. Leafly reviewed popular hemp products & chose…
A breakdown of the situation regarding hemp, cannabis, and THCA—courtesy of The Hemp Doctor. The…
Well, folks, it looks like Donald Trump might be the best thing to happen to…
In a policy memo that reeks of entitlement, the American Beverage Licensees (ABL) trade association…